top of page

EVRYSDI POWDER FOR ORAL SOLUTION 0.75 MG/ML

Product details

Registration number: SIN16349P

Classification: Prescription Only

Active ingredients: Risdiplam

Strength: 60 mg

Dosage form: POWDER, FOR SOLUTION

Route: ORAL; ENTERAL

Registrant: ROCHE SINGAPORE PTE. LTD.

ATC code: M09AX10

HSA approval date: 20 October 2021

Manufacturer(s):

  • F. Hoffmann-La Roche Ltd
  • F. Hoffmann-La Roche Ltd.

Manufacturing country/countries: SWITZERLAND

What are the HSA registration number and classification for EVRYSDI POWDER FOR ORAL SOLUTION 0.75 MG/ML?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN16349P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for EVRYSDI POWDER FOR ORAL SOLUTION 0.75 MG/ML?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Risdiplam

Strength: 60 mg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for EVRYSDI POWDER FOR ORAL SOLUTION 0.75 MG/ML?

According to the HSA dataset updated 7 August 2026:

Dosage form: POWDER, FOR SOLUTION

Route: ORAL; ENTERAL

Source for this answer

Who is the recorded registrant for EVRYSDI POWDER FOR ORAL SOLUTION 0.75 MG/ML?

According to the HSA dataset updated 7 August 2026:

Registrant: ROCHE SINGAPORE PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for EVRYSDI POWDER FOR ORAL SOLUTION 0.75 MG/ML?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • F. Hoffmann-La Roche Ltd
  • F. Hoffmann-La Roche Ltd.

Manufacturing country/countries: SWITZERLAND

Source for this answer

Where can I look up EVRYSDI POWDER FOR ORAL SOLUTION 0.75 MG/ML in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN16349P or the exact product name EVRYSDI POWDER FOR ORAL SOLUTION 0.75 MG/ML. The general register link does not preselect this product.

Source for this answer

What are the source dates for this EVRYSDI POWDER FOR ORAL SOLUTION 0.75 MG/ML record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this EVRYSDI POWDER FOR ORAL SOLUTION 0.75 MG/ML record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN16349P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page